Journal of Legal, Ethical and Regulatory Issues (Print ISSN: 1544-0036; Online ISSN: 1544-0044)


Fraudulent Financial Statements in Pharmaceutical Companies: Fraud Pentagon Theory Perspective

Author(s): Dodik Ariyanto, I Made Gilang Jhuniantara, Ni Made Dwi Ratnadi, I Gusti Ayu Made Asri Dwija Putri, Ayu Aryista Dewi

A fraudulent financial statement is an issue that continues to be discussed as a form of deviation from corporate governance. Covid-19 pandemic has also demanded managements to uphold the company's performance to have good public image. Thus, the present study sets out to scrutinize the fraud pentagon theory on fraudulent financial statements. Each element is not able to be tested directly. However, there are proxies. The pressure element is providing as a personal financial need. The opportunity is becoming the industry’s nature. Each of the quality of the external auditors as well as the turnover of board directors proposes rationalization and competence. The quantity of CEO’s appearance in photos is a proxy of arrogance. The testing was carried out on the registered pharmaceutical companies of the Indonesian stock exchange in the span of the 2015-2019 periods. The samples were selected by the means of sampling technique which is purposive. Data are scrutinized by the means of panel data regression. The analysis results show that the characteristic of the industry positively affects financial reports which are fraudulent. Changing top management positions such as directors can be an indication of financial reports which are fraudulent. The personal financial need variables, the caliber of external auditors and the quantity of CEO’s appearance in photos poses no effects on the fraudulent financial statements of the Indonesian's pharmaceutical companies.

Get the App